These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12092214)

  • 1. [The cardiovascular risk after renal transplantation (1): Hypertension and left ventricular hypertrophy].
    Covic A; Gusbeth-Tatomir P; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):651-6. PubMed ID: 12092214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk after renal transplantation(II): ischemic heart disease, hypercholesterolemia, hyperhomocysteinemia and smoking].
    Covic A; Gusbeth-Tatomir P; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):30-4. PubMed ID: 12635356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant management of end-stage renal disease patients to minimize posttransplant risk.
    Jardine AG
    Transplantation; 2000 Dec; 70(11 Suppl):SS46-50. PubMed ID: 11152231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of successful renal transplantation on left ventricular mass.
    Montanaro D; Gropuzzo M; Tulissi P; Vallone C; Boscutti G; Mioni R; Risaliti A; Baccarani U; Adani GL; Sainz M; Lorenzin D; Bresadola F; Mioni G
    Transplant Proc; 2005; 37(6):2485-7. PubMed ID: 16182718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk.
    Liefeldt L; Budde K
    Transpl Int; 2010 Dec; 23(12):1191-204. PubMed ID: 21059108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The comparison of selected parameters of structure and function of the cardiovascular system in patients with functioning graft on maintenance hemodialysis during a one year period].
    Króliczak M; Stompór T; Sułowicz W; Ochmański W; Królczyk J
    Przegl Lek; 2001; 58(10):894-902. PubMed ID: 11957815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S; Hennig L; Sternberg C; Dingerkus H; Ludat K; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):383-7. PubMed ID: 12908173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy in renal failure a review.
    Arodiwe EB
    Niger J Clin Pract; 2007 Mar; 10(1):83-90. PubMed ID: 17668722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risk of left ventricular hypertrophy in kidney transplant recipients: the potential role of mammalian target of rapamycin.
    Paoletti E; Cannella G
    Transplant Proc; 2009; 41(6 Suppl):S3-5. PubMed ID: 19651293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
    Tomilina NA; Gendlin GE; Zhidkova DA; Tronina OA; Fedorova ND
    Ter Arkh; 2009; 81(8):42-8. PubMed ID: 19799199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical care of renal transplant recipients after the first year post-transplantation].
    de Seigneux S; Hadaya K
    Rev Med Suisse; 2008 Mar; 4(147):596-8, 600-1. PubMed ID: 18402018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.